Concepedia

Yoko Yajima

YY

Statistics

Publications

4

Citations

70

H-Index

4

Active since

2011

Affiliations

National Cancer Center Hospital East(Current)

Bayer (Japan)

Yoko Yajima is an author at National Cancer Center Hospital East specializing in medicine, oncology, and hormonal therapy.

Publications per year

2011–2017

4

Publications

4

Phase 1 study of darolutamide (ODM-201): a new-generation androgen receptor antagonist, in Japanese patients with metastatic castration-resistant prostate cancer

Nobuaki Matsubara, Hirofumi Mukai, Ako Hosono et al. · Cancer Chemotherapy and Pharmacology · 2017 · 33 citations · Full text

, , +17

Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases

Hiroji Uemura, Hirotsugu Uemura, Nobuaki Matsubara et al. · International Journal of Clinical Oncology · 2017 · 14 citations · Full text

, , +17

QOL after head and neck reconstruction: Evaluation of Japanese patients using SF-36 and GOHAI

Makoto Hikosaka, Hiroko Ochiai, Masato Fujii et al. · Auris Nasus Larynx · 2011 · 12 citations

, , +8

Anti-Androgen Therapy for the Patients with Recurrent and/or Metastatic Salivary Duct Carcinoma Expressing Androgen Receptors: A Retrospective Study

Yoko Yajima, Satoshi Fujii, T. Kobayashi et al. · Annals of Oncology · 2012 · 11 citations · Full text

, , +14

1–4 of 4